Bioavailability of S(+)-ketoprofen after oral administration of different mixtures of ketoprofen enantiomers to dogs

Journal of Clinical Pharmacology

Volumn 38, Issue 12 SUPPL., 1998, Pages

  García, M Luisa ^a   Tost, Digna ^a   Vilageliu, Jaume ^b   López, Sergi ^b   Carganico, Germano ^c   Mauleón, David ^a  

^a Laboratorios Menarini SA   (Spain)

^b CIDA Sal   (Spain)

^c Menarini Ricerche SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

KETOPROFEN;

AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOG; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; ENANTIOMER; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RACEMIC MIXTURE;

EID: 0032433637     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcph.1998.38.s1.22     Document Type: Article

References (24)

1. Mauleón D, Artigas R, García ML, Carganico G: Preclinical and clinical development of dexketoprofen. Drugs 1996;52(Suppl. 5): 24-46.
2. Ferreira SH, Moncada S, Vane JR: Indomethacin and aspirin abolish prostaglandin release from spleen. Nature 1971;231:137-139.
3. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 1971;231:232-235.
4. Cashman JN: The mechanisms of action of NSAIDs in analgesia. Drugs 1996;52(Suppl. 5):13-23.
5. Geisslinger G, Schaible HG: New insights into the site and mode of antinociceptive action of flurbiprofen enantiomers. J Clin Pharmacol 1996;36:513-520.
6. Langman MJS, Weil J, Wainwright P, Lawson DH, Rawlins MD, Logan RFA, Murphy M, Vessey MP, Colin-Jones DG: Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343:1075-1078.
7. García Rodríguez LA, Jick H: Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343:769-772.
8. Suesa N, Fernández MF, Gutiérrez M, Rufat MJ, Rotllan E, Calvo L, Mauleón D, Carganico G: Stereoselective cyclooxygenase inhibition in cellular models by the enantiomers of ketoprofen. Chirality 1993;5:589-595.
9. Evans AM: Pharmacodynamics and pharmacokinetics of the profens: enantioselectivity, clinical implications, and special reference to S(+)-ibuprofen. J Clin Pharmacol 1996;36:7S-15S.
10. Caldwell J, Hutt AJ, Fournel-Gigleux S: The metabolic chiral inversion and dispositiorlal enantioselectivity of the 2-arylpropionic acids and their biological consequences. Biochem Pharmacol 1988;37:105-114.
11. Cooper SA: Ketoprofen in oral surgery pain: a review. J Clin Pharmacol 1988;28:S40-S46.
12. Hayball PJ, Nation RL, Bochner F: Enantioselective pharmacodynamics of the nonsteroidal anti-inflammatory drug ketoprofen: in vitro inhibition of human platelet cyclooxygenase activity. Chirality 1992;4:484-487.
13. Wechter WJ, Bigornia AE, Murray ED, Levine BH, Joung JW: Rac-flurbiprofen is more ulcerogenic than its (S)-enantiomer. Chirality 1993;5:492-493.
14. Carganico G, Mauleón D, García ML: A novel arylpropionic derivative, its method of preparation and its application as an analgesic. Patent WO 9411332, 1994.
15. Veys EM: 20 years' experience with ketoprofen. Scand J Rheumatol 1991;Suppl. 90:3-44.
16. Jamali F, Brocks DR: Clinical pharmacokinetics of ketoprofen and its enantiomers. Clin Pharmacokinet 1990;19:197-217.
17. Mauleón D, Mis R, Ginesta J, Ortega E, Vilageliu J, Basi N, Carganico G: Pharmacokinetics of ketoprofen enantiomers in monkeys following single and multiple oral administration. Chirality 1994;6:537-542.
18. Aberg G, Ciofalo VB, Pendleton RG, Ray G, Weddle D: Inversion of R- to S-ketoprofen in eight animal species. Chirality 1995; 7:383-387.
19. Abas A, Meffin PJ: Enantiomeric disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. IV. Ketoprofen disposition. J Pharmacol Exp Ther 1987;240:637-641.
20. Jamali F, Lovlin R, Aberg G: Bi-directional chiral inversion of ketoprofen in CD-1 mice. Chirality 1997;9:29-31.
21. Sunshine A, Laska EM: Onset-hastened/enhanced analgesia using S(+)-ketoprofen. Patent WO 8904658, 1989.
22. Shumaker RC: Basic interactive computer program for statistical and pharmacokinetic analysis of data. Drug Metab Rev 1986; 17:331-348.
23. Hayball PJ, Wrobel J, Tamblyn JG, Nation RL: The pharmacokinetics of ketorolac enantiomers following intramuscular administration of the racemate. Br J Clin Pharmacol 1994;37:75-78.
24. Jamali F, Mehvar R, Pasutto FM: Enantioselective aspects of drug action and disposition: therapeutic pitfalls. J Pharm Sci 1989;78:695-715.